Recruiting now—All ages
Financial Toxicity in Patients With Resected Soft Tissue and Bone Sarcomas
Sponsor: M.D. Anderson Cancer Center · NCT07215611 on ClinicalTrials.gov ↗
Conditions studied
Bone SarcomasFinancial Toxicity
What it tests
- data collectionother
Where it's running1 site
- Recruiting now
MD Anderson Cancer Center
Houston, Texas 77030
- Shalin S Patel, MD(contact)713-792-6268[email protected]
- Shalin S Patel, MD(principal investigator)
See the official eligibility language
Shown exactly as written on ClinicalTrials.gov. Your oncologist is the right person to judge whether it fits your situation.
Inclusion Criteria: * Participants who are seen preoperatively at our institution before surgery for primary malignant bone tumor or primary malignant soft tissue tumor will be identified. * Adult orthopedic oncology patients. Stratified by diagnosis of primary malignant bone tumor and primary malignant soft tissue tumor. Exclusion Criteria • Non-English subjects will not be recruited. Subjects are required to be able to read/write in English.
Updated 2026-04-30 on ClinicalTrials.gov. Always confirm current details with the study team or your oncologist.